Healthcare and Technology Shares Lead Broad Market Advance Amazon Allegedly Generated Millions Through Policy Later Deemed Illegal Japan Carmakers Face Margin Pressure as Aluminum Prices Surge Supply Risks Loom Perpetua Resources Secures 29 Billion US Loan for Idaho Critical Minerals Project Stocks Rally on Strong Earnings Iran Deal Talks in Focus Weekly Market Outlook CFTC Takes Legal Action Against Rhode Island in Growing Battle Over Prediction Market Regulation Knowles Q1 2026 Earnings EPS Surges Past Estimates Stock Rises 4 PERF Q1 2026 Earnings EPS Beats Estimates as Company Delivers Strong Profitability Radware RDWR Q1 2026 Earnings EPS Misses Estimates Yet Shares Gain TAP Q1 2026 Earnings EPS Crushes Estimates by 67 Stock Slips 2 Clean Harbors CLH Q1 2026 Earnings Earnings Beat Estimates Stock Advances Bicara Therapeutics BCAX Q1 2026 Earnings ClinicalStage Biotech Reports WiderthanExpected Loss Shares Rise CareCloud Preferred Stock CCLDO Holds Steady Near Key Support as Traders Assess Yield Appeal First Western Financial MYFW Holds Steady Near Support as RangeBound Trading Continues Leishen Energy Holding LSE Faces Pressure Stock Declines 354 as Support Levels Are Tested SuRo Capital Holds Steady Near Support as Price Edges Higher Natural Health Trends Corp NHTC Slides as Price Approaches Key Support Level Fed Dissenters Explain No Votes Disagree with Forward Guidance on Rate Cut Path OCCIN Q1 2026 Earnings Preferred Stock Reports Steep EPS Miss as Net Investment Income Falls Short Phoenix Asia Holdings PHOE Drops 582 Key Levels and Potential Scenarios NRDS Q1 2026 Earnings Earnings Beat Expectations as EPS Surprises Upward TKR Q1 2026 Earnings EPS Surprise of 11 Outshines Modest Stock Reaction Diageo Q1 2026 Earnings EPS Misses Estimates Amidst Mixed Market Sentiment Elemental Royalty Corporation Q1 2026 Earnings EPS Falls Short of Estimates as Stock Gains UAN Q1 2026 Earnings Strong EPS of 472 Driven by Favorable Nitrogen Market Conditions C4 Therapeutics Q1 2026 Earnings Strong EPS Beat Highlights Cost Discipline Amid PreRevenue Stage ANI Pharmaceuticals Q1 2026 Earnings Major EPS Beat Belies Subdued Market Response